Showing results (1111-1120 of 1,304) with videos related to
Sort By:
Pageof 131
Current HIV Research|July 13, 2020
Prevalence of COVID-19-like Symptoms among People Living with HIV, and Using Antiretroviral Therapy for Prevention and TreatmentSeyedAhmad SeyedAlinaghi, Maryam Ghadimi, Mahboubeh Hajiabdolbaghi, et al.Current HIV Research|April 27, 2021
Synthesis, Biophysical Characterization, and Anti-HIV-1 Fusion Activity of DNA Quadruplex-based Inhibitors with Dipeptide MT Hook ConjugationLiang Xu, Zeye Han, Hongqian RenCurrent HIV Research|May 18, 2012
Response to antiretroviral treatment after failure of NNRTI plus NRTIs-based therapy. Data from the ARCA collaborative groupElena Seminari, Annalisa De Silvestri, Genny Meini, et al.Current HIV Research|May 18, 2012
Adolescent HIV-1 transgenic rats: evidence for dopaminergic alterations in behavior and neurochemistry revealed by methamphetamine challengeLandhing M Moran, Michael Y Aksenov, Rosemarie M Booze, et al.Current HIV Research|May 18, 2012
Differential regulation of neurotoxin in HIV clades: role of cocaine and methamphetamineMadhavan P N Nair, Thangavel SamikkannuCurrent HIV Research|April 25, 2012
Sites of action of HIV-1 Vpu in BST-2/tetherin downregulationJuan F Arias, Yukie Iwabu, Kenzo TokunagaCurrent HIV Research|April 25, 2012
Transmembrane interactions of HIV-1 Vpu and tetherinFei Guo, Chen LiangCurrent HIV Research|January 4, 2012
Does GSS still maintain relevance on HAART outcome after the introduction of newest active antiretroviral drugs? 48 weeks resultsMassimiliano Ortu, Paola Vitiello, Fulvio Adorni, et al.Current HIV Research|January 4, 2012
Control of HIV latency by epigenetic and non-epigenetic mechanismsUri Mbonye, Jonathan KarnCurrent HIV Research|January 4, 2012
Models of HIV-1 persistence in the CD4+ T cell compartment: past, present and futureMudit Tyagi, Fabio RomerioPageof 131